300255.SZ

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

HealthcareBiotechnologyCNCNYPeers →Country macro →

$25.85

+0.47%Jun 18, 2026

Market cap

$23.76B

52w range

—

P / E

—

EPS

—

Volume

—

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Hebei Changshan Biochemical Pharmaceutical Co., Ltd.’s valuation

Enterprise value

$25.9B

Market cap

$23.76B

Net debt

—

Total debt

—

Cash & ST inv.

—

Capital structure

· balance sheet · 2026-06-20

Market capitalisation$23.76B

+ Total debt+—

− Cash & short-term investments−—

= Enterprise value$25.9B

Valuation

· key metrics · TTM

EV / EBITDA-120.0×

EV / Sales29.7×

EV / FCF-171.6×

Net debt / EBITDA-9.9×

Debt / Equity—

Arphra AIPlain-English read on the EV build & leverage